Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9605435rdf:typepubmed:Citationlld:pubmed
pubmed-article:9605435lifeskim:mentionsumls-concept:C0007289lld:lifeskim
pubmed-article:9605435lifeskim:mentionsumls-concept:C0028128lld:lifeskim
pubmed-article:9605435lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:9605435lifeskim:mentionsumls-concept:C0032231lld:lifeskim
pubmed-article:9605435lifeskim:mentionsumls-concept:C0033554lld:lifeskim
pubmed-article:9605435pubmed:issue7lld:pubmed
pubmed-article:9605435pubmed:dateCreated1998-6-8lld:pubmed
pubmed-article:9605435pubmed:abstractTextThe correlation between endogenous nitric oxide (NO) generation and prostaglandin biosynthesis was studied in rat carrageenin pleurisy induced by the injection of 0.2 mL of 1% lambda-carrageenin into the pleural cavity. The pleural exudate was collected at 4 hr and the amounts of NO2- + NO3- (NOx) and prostaglandin E2 (PGE2) measured. The NOx present in the inflammatory exudate was determined by measuring the NO2- with the Griess reaction, after the reduction of NO3- to NO2- using acid-washed cadmium powder. PGE2 was measured by radioimmunoassay. The NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 1-3-10 mg/kg subcutaneously) reduced NOx by 20 +/- 7%, 41 +/- 6% and 55 +/- 9% (P < 0.01) and PGE2 by 9 +/- 6%, 41 +/- 11% and 74 +/- 9% (P < 0.001). Conversely, L-arginine (300 mg/kg SC) increasedNOx by 39 +/- 7% (P < 0.01) and PGE2 by 78 +/- 6% (P < 0.001). The NO scavenger haemoglobin (Hb), coinjected into the pleural cavity (3 mg/site) with carrageenin, produced a parallel inhibition of NOx (65 +/- 16%, P < 0.001) and PGE2 (71 +/- 18%, P < 0.001). The soluble guanylate cyclase inhibitor methylene blue (Mb; 2 mg/site) had no effect. Moreover haemoglobin, but not methylene blue, was able to significantly suppress the L-arginine-induced increase of both NOx and PGE2. In each pleural exudate, independently from the animal treatment, the amount of NOx was highly correlated to the amount of PGE2 (r = 0.93, P < 0.001). These results suggest that in rat carrageenin pleurisy the modulation of the L-arginine:NO pathway results in a parallel modulation of prostaglandin biosynthesis. The interaction between cyclooxygenase and the NO pathway may represent an important mechanism for the modulation of the inflammatory response.lld:pubmed
pubmed-article:9605435pubmed:languageenglld:pubmed
pubmed-article:9605435pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9605435pubmed:citationSubsetIMlld:pubmed
pubmed-article:9605435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9605435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9605435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9605435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9605435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9605435pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9605435pubmed:statusMEDLINElld:pubmed
pubmed-article:9605435pubmed:monthAprlld:pubmed
pubmed-article:9605435pubmed:issn0006-2952lld:pubmed
pubmed-article:9605435pubmed:authorpubmed-author:SautebinLLlld:pubmed
pubmed-article:9605435pubmed:authorpubmed-author:Di RosaMMlld:pubmed
pubmed-article:9605435pubmed:authorpubmed-author:IalentiAAlld:pubmed
pubmed-article:9605435pubmed:authorpubmed-author:IanaroAAlld:pubmed
pubmed-article:9605435pubmed:issnTypePrintlld:pubmed
pubmed-article:9605435pubmed:day1lld:pubmed
pubmed-article:9605435pubmed:volume55lld:pubmed
pubmed-article:9605435pubmed:ownerNLMlld:pubmed
pubmed-article:9605435pubmed:authorsCompleteYlld:pubmed
pubmed-article:9605435pubmed:pagination1113-7lld:pubmed
pubmed-article:9605435pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:meshHeadingpubmed-meshheading:9605435-...lld:pubmed
pubmed-article:9605435pubmed:year1998lld:pubmed
pubmed-article:9605435pubmed:articleTitleRelationship between nitric oxide and prostaglandins in carrageenin pleurisy.lld:pubmed
pubmed-article:9605435pubmed:affiliationDepartment of Experimental Pharmacology, University of Naples Federico II, Italy.lld:pubmed
pubmed-article:9605435pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9605435pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9605435lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9605435lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9605435lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9605435lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9605435lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9605435lld:pubmed